Quick Dispatch:
Your semaglutide ec50 Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your semaglutide ec50 Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog ships.
Need Help?
Questions about semaglutide ec50 Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog, sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for semaglutide ec50 Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog in your area.
Recombinant Expression and Stapling of a Novel Long-Acting GLP-1R Peptide Agonist
21.09
In vitro potency (EC 50 ) estimated from concentration-response (cAMP)
24.20
Semaglutide | agonist of glucagon-like peptide-1 (GLP-1) receptor | CAS 910463-68-2 | NNC 0113-0217; NNC-0113-0217; Ozempic | long-acting GLP-1 analogue
23.18
GLP-1R and Diabetes
28.96
EC 50 and free fraction information used
23.11
2FA-Platform Generates Dual Fatty Acid-Conjugated GLP-1 Receptor Agonist TE-8105 with Enhanced Diabetes, Obesity, and NASH Efficacy Compared to Semaglutide
20.51
Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
28.38
.png.jpg)
